EDAP
$4.54
Edap Tms Sa ADR
($.07)
(1.52%)
EDAP
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.06
Revenue:  $14.56 Mil
Wednesday
Feb 12
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, November 13, 2019

What do you expect when EDAP reports earnings?
Beat
Meet
Miss

Where is EDAP's stock price going from here?
Up
Flat
Down
Stock chart of EDAP
Analysts
Summary of analysts' recommendations for EDAP
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.
Peers
MedtronicVarian Medical SystemsCONMED